SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dogecoin (DOGE) is a cryptocurrency . Users are able to generate DOGE through the process of mining. Dogecoin has a current supply of 156,738,272,860.16806072. The last known price of Dogecoin is 0.06457313 USD and is down -2.71 over the last 24 hours. It is currently trading on 1545 active market(s) with $672,498,596.98 traded over the last 24 hours. More information can be found at http://dogecoin.com/.

Dogecoin

Dogecoins prolonged slide and underperformance are dominating discussion, with traders describing a persistent downtrend and fearing further losses. Some holders are buying the dip and citing possible technical bottoming signals, while others see the coin as losing relevance and expect more downside.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,631. The last known price of Bitcoin is 68,229.80907922 USD and is down -4.02 over the last 24 hours. It is currently trading on 12780 active market(s) with $42,739,134,877.94 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins sharp slide below a key psychological level and forced liquidations of leveraged long positions dominate discussion, with traders also citing broader risk-off pressure from inflation concerns, a stronger dollar and weakness in tech. The community is split between expecting further downside and treating the selloff as a buying opportunity.

Delta Air Lines, Inc. engages in the provision of scheduled air transportation for passengers and cargo. It operates through the Airline and Refinery segments. The Airline segment provides scheduled air transportation for passengers and cargo. The Refinery segment provides jet fuel to the airline segment. The company was founded by Collett Everman Woolman in 1928 and is headquartered in Atlanta, GA.

Delta Air Lines, Inc.

The FAAs nationwide departure ground stop, attributed to an air-traffic-control communications failure and later lifted, is driving attention to Delta and other airlines. Traders are weighing disruption and possible cost fallout against the view that this was a temporary outage; cyberattack claims remain unconfirmed.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.0099454 USD and is down -2.36 over the last 24 hours. It is currently trading on 1896 active market(s) with $2,532,309,467.05 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRPs sharp slide toward a key psychological support level dominates discussion, with traders pointing to broader crypto weakness and debating whether the selloff signals further downside or a buying opportunity. Bearish posts also question Ripples value to the token and cite founder-token sales, while long-term holders continue to accumulate.

American Airlines Group, Inc. is a holding company, which engages in the operation of a network carrier through its principal wholly owned mainline operating subsidiary, American. The firm offers air transportation for passengers and cargo. It operates through the following geographical segments: Domestic, Latin America, Atlantic, and Pacific. The company was founded on December 9, 2013, and is headquartered in Fort Worth, TX.

American Airlines Group Inc

A nationwide FAA ground stop tied to air-traffic-control communications failures pressured American and other airline shares; the stop was lifted, but traders are debating whether flight disruptions will linger or the selloff will reverse. Speculation about a cyberattack circulated, though no attack was confirmed.

United Airlines Holdings, Inc. is a holding company, which engages in the provision of transportation services. It operates through the following geographical segments: Domestic, Atlantic, Pacific, and Latin America. The company was founded on December 30, 1968 and is headquartered in Chicago, IL.

United Airlines Holdings Inc

A nationwide FAA ground stop tied to an air-traffic-control communications outage has put United and other airlines in focus; traders are weighing potential disruption to flights against a rebound now that restrictions have been lifted. Cyberattack theories remain speculation, with the cause described as a communications issue under investigation.

L3Harris Technologies, Inc. engages in the provision of defense and commercial technologies across the air, land, sea, space, and cyber domains. It operates through the following segments: Communication Systems, Integrated Mission Systems, Space and Airborne Systems, and Aerojet Rocketdyne. The Communication Systems segment enables warfighters across all domains with solutions critical to mission success even in the most contested environments. The Integrated Mission Systems segment focuses on the differentiated mission capabilities and prime systems integration for the air, land, and sea domains. The Space and Airborne Systems segment provides full mission solutions as a prime and subsystem integrator in the space, airborne, and cyber domains. The Aerojet Rocketdyne segment includes propulsion, power and armament products and systems to U.S. government, including the DoD, National Aeronautics and Space Administration (“NASA”) and major aerospace and defense prime contractors. The company was founded in 1890 and is headquartered in Melbourne, FL.

L3Harris Technologies Inc

Attention centers on reports that an FAA air-traffic communications outage involved a failed update to a network managed by L3Harris, disrupting flights. Traders debate L3Harriss responsibility and potential liability, while claims of a cyberattack remain unconfirmed.

Internet Computer (ICP) is a cryptocurrency launched in 2021. Internet Computer has a current supply of 558,955,776.17969788. The last known price of Internet Computer is 2.47157656 USD and is down -4.42 over the last 24 hours. It is currently trading on 448 active market(s) with $64,748,398.45 traded over the last 24 hours. More information can be found at https://internetcomputer.org/.

Internet Computer

ICPs weakness is fueling debate over whether its Cloud Engines and decentralized cloud/AI infrastructure can gain real adoption and drive network usage. Bulls point to the claimed commercial rollout and sovereign-cloud use cases, while skeptics say price action and adoption remain weak and the project needs to show concrete results.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategy is under pressure as Bitcoins sharp selloff coincides with its confirmed removal from MSCI indexes, raising concerns about passive-fund selling and the companys ability to fund further Bitcoin purchases through stock issuance. The community is largely bearish over Bitcoin weakness, dilution and potential outflows, though some traders view the decline as a buying opportunity if Bitcoin stabilizes.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs prolonged selloff is driving discussion, with traders worried that its large at-the-market share-sale authorization could dilute shareholders and citing broader weakness in space stocks. Others remain bullish on the longer-term potential of Googles Project Suncatcher and growing defense and government business, while calling for stronger contract news.

statis crypto Watchlist

Ethereum

Solana

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Outlook Therapeutics Names Greg DiPasquale Chief Commercial Officer

(RTTNews) - On Friday, Outlook Therapeutics (OTLK), a biopharmaceutical company developing and commercializing LYTENAVA for retinal diseases, announced Greg DiPasquale as Chief Commercial Officer...

OTLK Q3 Earnings Call Maps LYTENAVA U.S. Launch and Sales Ramp

Outlook Therapeutics targets a year-end 2026 U.S. LYTENAVA launch, with $50M-$75M in first-year net revenues and a ramp tied to reimbursement.

Transcript: Outlook Therapeutics Q3 2026 Earnings Conference Call

Outlook Therapeutics (NASDAQ:OTLK) released third-quarter financial results and hosted an earnings call on Friday. Read the complete transcript below.
This transcript is brought to you by Benzinga APIs. For real-timeread more...

Outlook Therapeutics, Inc. (OTLK) Reports Q3 Loss, Lags Revenue Estimates

Outlook Therapeutics, Inc. (OTLK) delivered earnings and revenue surprises of 0.00% and -99.25%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Outlook Therapeutics Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Outlook Therapeutics (NASDAQ: OTLK) to release Q3 earnings on Aug. 14. Analysts expect a loss of 8 cents/share. Analysts rate it Neutral or Buy.read more...

Zealand Pharma A/S (ZLDPF) Surpasses Q2 Earnings and Revenue Estimates

Zealand Pharma AS (ZLDPF) delivered earnings and revenue surprises of +2,150.00% and +756.67%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Why Did OTLK Stock Crash In Pre-Market Today?

Equity

Outlook Therapeutics is looking to sell about 55.6 million common shares, accompanied by warrants, at a 10% discount over the stock’s closing price on Wednesday.

OTLK Up More Than 300% in 3 Months: Here's What You Should Know

Outlook Therapeutics rallies 311.8% in three months as Lytenava's FDA approval boosts optimism ahead of its planned U.S. launch by year-end.

iRhythm Holdings, Inc. (IRTC) Tops Q2 Earnings and Revenue Estimates

IRHYTHM HLDGS (IRTC) delivered earnings and revenue surprises of +5,900.00% and +2.18%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Outlook Therapeutics, Inc. (OTLK) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Outlook Therapeutics, Inc. (OTLK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

This account has been verified as an official OTLK representative.

Verified Account

Outlook Therapeutics

Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Iselin, NJ.

Outlook Therapeutics Inc

Neutral Sentiment

<ul class="summary-bullets"><li>Outlook plans to use the funds, alongside its existing cash, to support the U.S. commercial launch of its eye drug Lytenava.</li><li>Lytenava received U.S. Food and Drug Administration approval for wet age-related macular degeneration last month.</li><li>Wall Street is expecting a third-quarter loss of $0.07 per share on Friday, narrower than last year’s $0.44 per share loss, according to Fiscal.ai.</li></ul>Shares of Outlook Therapeutics (OTLK) tanked nearly 24% in pre-market trading on Thursday, after the biotech firm announced a discounted share offering to fund the commercial launch of its recently approved eye drug in the U.S.<a href="https://stocktwits.com/symbol/OTLK">OTLK stock</a> is tracking its third successive decline.<h2 class="st-heading-2">Offering At A 10% Discount</h2>Outlook Therapeutics is looking to sell about 55.6 million common shares, each accompanied by a warrant to purchase another share, at a combined price of $0.99. This represents a 10% discount over the stock’s closing price on Wednesday.The warrants carry an exercise price of $1.10 and expire after five years. Underwriters also have a 30-day option to purchase up to 8.3 million additional shares and an equal number of warrants. The offering is expected to close on Aug. 14, 2026.Outlook expects gross proceeds of roughly $55 million, which it plans to use, alongside its existing cash, to support the U.S. commercial launch of Lytenava as well as for general corporate purposes.<h2 class="st-heading-2">Lytenava Set For U.S. Launch&nbsp;</h2>Last month, the U.S. Food and Drug Administration (FDA) <a href="https://stocktwits.com/news-articles/markets/equity/otlk-fda-wet-amd-drug-analysts-see-upside/cZZx4zAR7CX">approved</a> Lytenava for wet age-related macular degeneration. Outlook describes it as the only FDA-approved Bevacizumab formulation developed specifically for use in the eye.The approval marked a turnaround after the FDA rejected Outlook’s application in December 2025 and requested additional evidence. Following an appeal, the agency’s Office of New Drugs concluded in May that no further clinical trials were needed.Lytenava is already approved in the EU and U.K., and the company expects a U.S. launch before year-end.<h2 class="st-heading-2">OTLK Q3 Earnings Due Friday</h2>Meanwhile, the company reports third-quarter results on Friday, with Wall Street expecting a loss of $0.07 per share, narrower than last year’s $0.44 per share loss, according to Fiscal.ai. The stock has a 12-month price target of $5.40, according to Koyfin data, while three of the four analysts covering the stock have a ‘Buy’ rating and one ‘hold’ rating.<h2 class="st-heading-2">Retail Remains Bearish On OTLK</h2>Retail sentiment surrounding OTLK on Stocktwits remained in the ‘bearish’ zone over the past 24 hours, amid a 330% jump in message volumes.One user said the company didn’t raise enough funds.<stembedurl>https://stocktwits.com/HarmonyPioneer67/message/661747443</stembedurl>Another user felt the offering should have been carried out when the stock traded around $1.60.<stembedurl>https://stocktwits.com/Racsoracso/message/661743798</stembedurl>The stock has seen strong buying interest so far in 2026, gaining over 60%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of Outlook Therapeutics is displayed on the screen of a smart tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

SPDR S&P Biotech ETF

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$0.413
Prev Close	$0.4401
Open	$0.4629
Dividend Yield	0.00%
50-Day Moving Average	$0.5635
Beta	1.18
Avg. Volume	4.2M
PE Ratio	-0.38

52-Week High	$2.54
52-Week Low	$0.1611
Market Capitalization	$107.14M
EPS (Annual)	-$1.79
Price to Book	-7.43
Revenue Per Employee	$83,149.12

Feed

News

Sentiment

Earnings

Fundamentals

Info

OTLK Fundamentals